title: In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
abstract: The in vitro activities of ceftaroline-avibactam, ceftaroline, and comparative agents were determined for a collection of bacterial pathogens frequently isolated from patients seeking care at 15 Canadian hospitals from January 2010 to December 2012. In total, 9,758 isolates were tested by using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method (document M07-A9, 2012), with MICs interpreted by using CLSI breakpoints (document M100-S23, 2013). Ceftaroline-avibactam demonstrated potent activity (MIC90, ≤ 0.5 μg/ml) against Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis, Enterobacter cloacae, Enterobacter aerogenes, Serratia marcescens, Morganella morganii, Citrobacter freundii, and Haemophilus influenzae; >99% of isolates of E. coli, K. pneumoniae, K. oxytoca, P. mirabilis, M. morganii, C. freundii, and H. influenzae were susceptible to ceftaroline-avibactam according to CLSI MIC interpretative criteria for ceftaroline. Ceftaroline was less active than ceftaroline-avibactam against all species of Enterobacteriaceae tested, with rates of susceptibility ranging from 93.9% (P. mirabilis) to 54.0% (S. marcescens). All isolates of methicillin-susceptible Staphylococcus aureus (MIC90, 0.25 μg/ml) and 99.6% of methicillin-resistant S. aureus isolates (MIC90, 1 μg/ml) were susceptible to ceftaroline; the addition of avibactam to ceftaroline did not alter its activity against staphylococci or streptococci. All isolates of Streptococcus pneumoniae (MIC90, 0.03 μg/ml), Streptococcus pyogenes (MIC90, ≤ 0.03 μg/ml), and Streptococcus agalactiae (MIC90, 0.015 μg/ml) tested were susceptible to ceftaroline. We conclude that combining avibactam with ceftaroline expanded its spectrum of activity to include most isolates of Enterobacteriaceae resistant to third-generation cephalosporins, including extended-spectrum β-lactamase (ESBL)- and AmpC-producing E. coli and ESBL-producing K. pneumoniae, while maintaining potent activity against staphylococci and streptococci.
authors: Diagnostic Services Manitoba.
authors: James A
authors: JA
authors: Karlowsky
authors: Heather J
authors: HJ
authors: Adam
authors: Melanie R
authors: MR
authors: Baxter
authors: Philippe R S
authors: PR
authors: Lagacé-Wiens
authors: Andrew J
authors: AJ
authors: Walkty
authors: Daryl J
authors: DJ
authors: Hoban
authors: George G
authors: GG
authors: Zhanel
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D053961:Azabicyclo Compounds / Q000494:pharmacology*; D002170:Canada; D002511:Cephalosporins / Q000494:pharmacology*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D062486:Public Health Surveillance; D012189:Retrospective Studies; D000097583:Ceftaroline
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D002511:Cephalosporins; D000097583:Ceftaroline; C543519:avibactam
references: Antimicrob Agents Chemother. 2010 Jul;54(7):3027-30
references: 20404122
references: J Antimicrob Chemother. 2010 Mar;65(3):586-8
references: 20085997
references: Antimicrob Agents Chemother. 2013 Jun;57(6):2496-505
references: 23439634
references: Drugs. 2013 Feb;73(2):159-77
references: 23371303
references: Antimicrob Agents Chemother. 2013 Jul;57(7):3178-81
references: 23629712
references: J Clin Microbiol. 2005 Dec;43(12):6147-9
references: 16333116
references: Drugs. 2010 Apr 16;70(6):651-79
references: 20394454
references: J Antimicrob Chemother. 2009 Sep;64(3):659-60
references: 19578080
references: Antimicrob Agents Chemother. 2008 May;52(5):1846-9
references: 18299417
references: Can J Infect Dis Med Microbiol. 2008 Jul;19(4):273-81
references: 19436507
references: Antimicrob Agents Chemother. 2010 Apr;54(4):1627-32
references: 20100877
references: Antimicrob Agents Chemother. 2012 Sep;56(9):4779-85
references: 22733066
references: Antimicrob Agents Chemother. 2009 Mar;53(3):1271-4
references: 19114671
references: Antimicrob Agents Chemother. 2011 Jun;55(6):2837-46
references: 21402844
references: Antimicrob Agents Chemother. 1998 Apr;42(4):879-84
references: 9559800
references: J Antimicrob Chemother. 2010 Jul;65(7):1428-32
references: 20478991
references: Antimicrob Agents Chemother. 2010 May;54(5):1670-7
references: 20194704
references: Diagn Microbiol Infect Dis. 2013 Jul;76(3):347-51
references: 23623385
references: FEMS Microbiol Lett. 1999 Apr 15;173(2):459-65
references: 10227175
references: J Antimicrob Chemother. 2012 Jun;67(6):1354-8
references: 22441578
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3501-12
references: 16048970
references: Antimicrob Agents Chemother. 2011 Jul;55(7):3220-5
references: 21518838
references: Antimicrob Agents Chemother. 2004 Apr;48(4):1204-14
references: 15047521
references: Antimicrob Agents Chemother. 2012 Jan;56(1):258-70
references: 22024819
references: Antimicrob Agents Chemother. 2012 Jun;56(6):2933-40
references: 22470115
references: Antimicrob Agents Chemother. 2008 Sep;52(9):3398-407
references: 18625769
references: J Antimicrob Chemother. 2007 Aug;60(2):300-11
references: 17548456
references: Antimicrob Agents Chemother. 2013 Apr;57(4):1982-8
references: 23380730
references: Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8
references: 22753474
references: Drugs. 2009;69(7):809-31
references: 19441869
references: Eur J Clin Microbiol Infect Dis. 1996 May;15(5):398-402
references: 8793399